Lobbying Filing Details

Total Spending

$90,000

Activities

1

Lobbyists

6

Gov't Entities

4

Filing Information
Filing UUID:
63a0a5e3-4c5c-4f7b-af1d-54f3e32a5c6b
Type:
Q3 - 3rd Quarter - Report
Period:
2025 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 21, 2025 at 2:29 AM
Income:
$90,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
TODD STRATEGY GROUP

​Government Affairs Consulting Firm.

Washington, District of Columbia
Client
VIAL HEALTH TECHNOLOGY, INC.

Vial is a clinical stage biopharmaceutical company.

California, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

New approach methods. FDA Roadmap.

Lobbyists (6)
  • DANIEL M TODD
  • PAUL EDATTEL
  • NICHOLAS UEHLECKE
  • TED LEHMAN
  • KATHERINE FLEMING COTTON
  • ERIC BERGREN
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Food & Drug Administration (FDA)

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.